M&T Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1
Closed -$1K 1761
2016
Q2
$1K Buy
+1
New +$69 ﹤0.01% 1684
2015
Q1
Sell
-2,455
Closed -$1K 2137
2014
Q4
$1K Hold
2,455
﹤0.01% 2107
2014
Q3
$6K Buy
+2,455
New +$199K ﹤0.01% 2211

Other funds holding NVS

M&T Bank's NVS Position: Q2 2026 in Review

M&T Bank increased its Novartis (NVS) stake by 5.3% in Q2 2026, buying an estimated $1.39M and bringing the position to 183,359 shares worth $28.7M. The position accounts for 0.08% of the portfolio, ranked #175.

M&T Bank first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $30M in Q1 2015. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • M&T Bank held 183,359 shares of Novartis worth $28.7M as of Q2 2026.
  • M&T Bank bought 9,264 Novartis shares in Q2 2026, an estimated $1.39M.
  • Novartis made up 0.08% of M&T Bank's portfolio in Q2 2026, its #175 holding.
  • M&T Bank first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • M&T Bank's Novartis position peaked at $30M in Q1 2015.
  • 1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.